Congratulations to Professor Wei Chen and his lab at the University of Oklahoma for their publication in one of the top ranked oncology and immunology peer-reviewed journals, the Journal for ImmunoTherapy of Cancer (JITC), on their paper, “Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors”.

Check out this key publication on how ablation + IP-001 leads to activation of T cells and a de novo antitumor T-cell response.  Publication link:  Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors | Journal for ImmunoTherapy of Cancer (bmj.com)